Results 131 to 140 of about 112,758 (355)

The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation. [PDF]

Virol J, 2021
Ridha M, Jones DG, Lerner DP, Vytopil M, Voetsch B, Burns JD, Ramineni A, Raibagkar P.   +7 more
europepmc   +1 more source

A Rare Case of Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Settings of Etanercept Use and Epstein-Barr Virus Infection [PDF]

, 2021
Giulio Ciprian, Jessica Khoury, Thomas J Raimondo   +2 more
openalex   +1 more source

Drug Hypersensitivity: A Correlation Study From Histopathology to Clinic

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Drug hypersensitivity (DH) can present with varied clinical and pathological manifestations that may mislead the referring physician. Available data regarding the concordance between pathological diagnosis and clinical findings in DH are scarce.
Olivier Philip, Morgane Stichelbout, Marie Verhasselt‐Crinquette, Baptiste Mille, Delphine Staumont‐Sallé, Frédéric Dezoteux   +5 more
wiley   +1 more source

25-Hydroxycholesterol Inhibits Kaposi's Sarcoma Herpesvirus and Epstein-Barr Virus Infections and Activates Inflammatory Cytokine Responses. [PDF]

mBio, 2021
Serquiña AKP, Tagawa T, Oh D, Mahesh G, Ziegelbauer JM.   +4 more
europepmc   +1 more source

Effects of targeting sumoylation processes during latent and induced Epstein-Barr virus infections using the small molecule inhibitor ML-792. [PDF]

Antiviral Res, 2021
Garcia P, Harrod A, Jha S, Jenkins J, Barnhill A, Lee H, Thompson M, Williams JP, Barefield J, Mckinnon A, Suarez P, Shah A, Lowrey AJ, Bentz GL.   +13 more
europepmc   +1 more source

Clinical Features of the Course of Chronic Epstein-barr Viral Infection Depending on the Type of Immune Reaction of Organism [PDF]

, 2016
The results of the study of the main regulatory cytokines levels in patients with chronic forms of EBV-infection (CEBV) are presented the work.Aim of research.
Liadova, T. (Tatiana)
core  

Targeted eradication of EBV-positive cancer cells by CRISPR/dCas9-mediated EBV reactivation in combination with ganciclovir

mBio
Epstein-Barr virus (EBV) is a ubiquitous human tumor virus that establishes lifelong, persistent infections in B cells. The presence of EBV in cancer cells presents an opportunity to target these cells by reactivating the virus from latency.
Febri Gunawan Sugiokto, Renfeng Li
doaj   +1 more source

Community-acquired pneumonia in children: cell-free plasma sequencing for diagnosis and management. [PDF]

, 2019
Community-acquired pneumonia (CAP) is a common cause of pediatric hospital admission. Empiric antibiotic therapy for hospitalized children with serious CAP now targets the most likely pathogen(s), including those that may demonstrate significant ...
Bradley, John S, Cannavino, Christopher R, Coufal, Nicole G, Farnaes, Lauge, Foley, Jennifer, Hong, David K, Pong, Alice, Ryan Loker, Kathleen, Wilke, Julianne   +8 more
core  

Control of Epstein-Barr Virus (EBV) in the Oral Cavity Is Associated With Persistence of Oral Human Papillomavirus (HPV)16/18 Among Men From the HPV Infection in Men Study [PDF]

, 2022
Brittney L. Dickey, Anna R. Giuliano, Bradley Sirak, Martha Abrahamsen, Eduardo Lazcano‐Ponce, Luisa L. Villa, Anna E. Coghill   +6 more
openalex   +1 more source

Predicting Different Recurrence Risk in HNSCC Using Circulating Inflammatory and T‐Cell Biomarkers

The Laryngoscope, EarlyView.
ABSTRACT Objective Head and neck squamous cell carcinoma (HNSCC) lacks reliable prognostic circulating biomarkers, and the role of the immune system in its progression remains incompletely understood. This study aimed to evaluate the prognostic value of systemic inflammatory and immune biomarkers in surgically treated patients with primary oral cavity (
Riccardo Gili, Paola Lovino Camerino, Luca Lalli, Elisa Bellini, Chiara Tagliaferri, Filippo Bruno Lanza, Stefania Vecchio, Simone Caprioli, Giorgio Peretti, Lucia Del Mastro, Filippo Marchi   +10 more
wiley   +1 more source